ELIAS Animal Health

Based in Olathe, Kan., ELIAS Animal Health is a medical biotechnology company advancing its novel therapies for the treatment of cancer in pets. The company’s lead product candidate, the ELIAS cancer immunotherapy (ECI®), an autologous prescription product, is available to veterinarians under 9 CFR 103.3 as an experimental product for canine osteosarcoma. Efficacy and safety have not been established. The company’s novel therapeutic approach offers the promise of improved clinical outcomes and the potential for fundamentally changing the way cancer is treated.